Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 251

1.

Apolipoprotein Eepsilon4 modifies Alzheimer's disease onset in an E280A PS1 kindred.

Pastor P, Roe CM, Villegas A, Bedoya G, Chakraverty S, García G, Tirado V, Norton J, Ríos S, Martínez M, Kosik KS, Lopera F, Goate AM.

Ann Neurol. 2003 Aug;54(2):163-9.

PMID:
12891668
2.

E280A PS-1 mutation causes Alzheimer's disease but age of onset is not modified by ApoE alleles.

Lendon CL, Martinez A, Behrens IM, Kosik KS, Madrigal L, Norton J, Neuman R, Myers A, Busfield F, Wragg M, Arcos M, Arango Viana JC, Ossa J, Ruiz A, Goate AM, Lopera F.

Hum Mutat. 1997;10(3):186-95.

PMID:
9298817
3.

Gene polymorphism in apolipoprotein E and presenilin-1 in patients with late-onset Alzheimer's disease.

Cui T, Zhou X, Jin W, Zheng F, Cao X.

Chin Med J (Engl). 2000 Apr;113(4):340-4.

PMID:
11775232
4.

Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.

Davidson Y, Gibbons L, Pritchard A, Hardicre J, Wren J, Tian J, Shi J, Stopford C, Julien C, Thompson J, Payton A, Thaker U, Hayes AJ, Iwatsubo T, Pickering-Brown SM, Pendleton N, Horan MA, Burns A, Purandare N, Lendon CL, Neary D, Snowden JS, Mann DM.

J Neurol Neurosurg Psychiatry. 2006 Apr;77(4):515-7.

5.

No association between the intronic presenilin 1 polymorphism and Alzheimer's disease in the Chinese population.

Wu X, Jiang S, Lin S, Tang G, Feng G, Qian Y, Wang D, Ren D, Gu N.

Am J Med Genet. 1999 Feb 5;88(1):1-3.

PMID:
10050959
6.

The 4,752 C/T polymorphism in the presenilin 1 gene increases the risk of Alzheimer's disease in apolipoprotein E4 carriers.

Matsubara-Tsutsui M, Yamagata H, Morishima A, Nakura J, Mitsuda N, Kamino K, Kondo I, Miki T.

Intern Med. 2002 Oct;41(10):823-8.

7.

Novel presenilin 1 mutation with profound neurofibrillary pathology in an indigenous Southern African family with early-onset Alzheimer's disease.

Heckmann JM, Low WC, de Villiers C, Rutherfoord S, Vorster A, Rao H, Morris CM, Ramesar RS, Kalaria RN.

Brain. 2004 Jan;127(Pt 1):133-42. Epub 2003 Oct 21.

PMID:
14570818
8.

Case-control study of presenilin-1 intronic polymorphism in sporadic early and late onset Alzheimer's disease.

Yasuda M, Hirono N, Maeda K, Imamura T, Mori E, Tanaka C.

J Neurol Neurosurg Psychiatry. 1999 Jun;66(6):722-6.

9.
10.

T/G polymorphism at intron 9 of presenilin 1 gene is associated with, but not responsible for sporadic late-onset Alzheimer's disease in Japanese population.

Nishiwaki Y, Kamino K, Yoshiiwa A, Sato N, Tateishi K, Takeda M, Kobayashi T, Yamamoto H, Nonomura Y, Yoneda H, Sakai T, Imagawa M, Miki T, Ogihara T.

Neurosci Lett. 1997 May 16;227(2):123-6.

PMID:
9180219
11.

No association between a presenilin 1 polymorphism and Alzheimer disease.

Romas SN, Mayeux R, Tang MX, Lantigua R, Medrano M, Tycko B, Knowles J.

Arch Neurol. 2000 May;57(5):699-702.

PMID:
10815136
12.

Polymorphisms in the presenilin 1 and presenilin 2 genes and risk for sporadic Alzheimer's disease.

Combarros O, Alvarez-Arcaya A, Oterino A, Berciano J, Delgado-Rodríguez M, Peña N, Fernández-Viadero C, Luis Pérez-López J, Setién S, Carvajal A.

J Neurol Sci. 1999 Dec 15;171(2):88-91.

PMID:
10581373
13.

ApoE genotype is a risk factor in nonpresenilin early-onset Alzheimer's disease families.

Houlden H, Crook R, Backhovens H, Prihar G, Baker M, Hutton M, Rossor M, Martin JJ, Van Broeckhoven C, Hardy J.

Am J Med Genet. 1998 Feb 7;81(1):117-21.

PMID:
9514597
14.

Apolipoprotein E Pittsburgh variant is not associated with the risk of late-onset Alzheimer's disease in a Spanish population.

Baron M, Jimenez-Escrig A, Orensanz L, Simon J, Perez-Tur J.

Am J Med Genet B Neuropsychiatr Genet. 2003 Jul 1;120B(1):121-4.

PMID:
12815750
15.

Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.

Raygani AV, Zahrai M, Raygani AV, Doosti M, Javadi E, Rezaei M, Pourmotabbed T.

Neurosci Lett. 2005 Feb 25;375(1):1-6. Epub 2004 Nov 26.

PMID:
15664112
16.

A newly identified polymorphism in the apolipoprotein E enhancer gene region is associated with Alzheimer's disease and strongly with the epsilon 4 allele.

Mui S, Briggs M, Chung H, Wallace RB, Gomez-Isla T, Rebeck GW, Hyman BT.

Neurology. 1996 Jul;47(1):196-201.

PMID:
8710077
17.

Alzheimer's disease due to an intronic presenilin-1 (PSEN1 intron 4) mutation: A clinicopathological study.

Janssen JC, Hall M, Fox NC, Harvey RJ, Beck J, Dickinson A, Campbell T, Collinge J, Lantos PL, Cipolotti L, Stevens JM, Rossor MN.

Brain. 2000 May;123 ( Pt 5):894-907.

PMID:
10775535
18.

Polymorphism of the regulatory region of the presenilin-2 gene in sporadic Alzheimer's disease: a case-control study.

Quan W, Yasuda M, Hashimoto M, Yamamoto Y, Ishii K, Kazui H, Mori E, Kakigi T, Maeda K.

J Neurol Sci. 2006 Jan 15;240(1-2):71-5. Epub 2005 Oct 17.

PMID:
16233903
19.

No association of presenilin-1 intronic polymorphism and Alzheimer's disease in Australia.

Taddei K, Yang D, Fisher C, Clarnette R, Hallmayer J, Barnetson R, Maller R, Brooks WS, Whyte S, Nicholson GA, Masters CL, Broe GA, Gandy SE, Martins RN.

Neurosci Lett. 1998 May 1;246(3):178-80.

PMID:
9792621
20.

A polymorphism of the interleukin-1 beta gene at position +3953 influences progression and neuro-pathological hallmarks of Alzheimer's disease.

Licastro F, Veglia F, Chiappelli M, Grimaldi LM, Masliah E.

Neurobiol Aging. 2004 Sep;25(8):1017-22.

PMID:
15212826

Supplemental Content

Support Center